Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Partial Agonist/SPP1 Splice Variant Strategy: Splice-Switching Therapeutics

SPP1 splicing factors · synaptic biology · -
Composite
0.375
Price
$0.38
Evidence For
0
Evidence Against
0

Full-length SPP1 (exon 5+) induces pathological phagocytosis while alternative splice variant SPP1Δ5 promotes neuroprotection without synaptic targeting. Splice-switching compounds (targeting HNRNPK, PTBP1) rebalance microglial states. Most speculative hypothesis with no human brain splice variant evidence and significant off-target risk.

Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)

CD55 (DAF), CD46 (MCP) · synaptic biology · -
Composite
0.720
Price
$0.72
Evidence For
0
Evidence Against
0

Excitatory synapses on specific neuronal compartments (distal dendrites of CA1 pyramidal neurons) express low levels of membrane complement regulators CD46 and CD55, while inhibitory synapses and synapses on interneurons express high levels. During anesthesia, C1q binds preferentially to synapses lacking these regulators. Local C3a generation serves as a potent 'find-me' signal to recruiting microglia specifically to these unprotected synapses. Peptidomimetic enhancement of complement regulation

Verdict Summary

1/10
dimensions won
Partial Agonist/SPP1 Splice Variant Stra
9/10
dimensions won
Differential Complement Regulator Expres

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.35
0.75
Evidence
0.30
0.72
Novelty
0.80
0.75
Feasibility
0.25
0.70
Impact
0.45
0.80
Druggability
0.28
0.70
Safety
0.40
0.50
Competition
0.70
0.80
Data
0.22
0.55
Reproducible
0.30
0.72

Score Breakdown

DimensionPartial Agonist/SPP1 Splice VaDifferential Complement Regula
Mechanistic0.3500.750
Evidence0.3000.720
Novelty0.8000.750
Feasibility0.2500.700
Impact0.4500.800
Druggability0.2800.700
Safety0.4000.500
Competition0.7000.800
Data0.2200.550
Reproducible0.3000.720

Evidence

Partial Agonist/SPP1 Splice Variant Strategy: Splice-Switchi

No evidence citations yet

Differential Complement Regulator Expression on Synaptic Mem

No evidence citations yet

Debate Excerpts

Partial Agonist/SPP1 Splice Variant Strategy: Spli

4 rounds · quality: 0.69

Theorist

# Therapeutic Hypotheses: SPP1 in Alzheimer's Disease Synaptic Pathology ## Hypothesis 1: Stage-Dependent Biphasic SPP1 Targeting **Title:** Early-phase SPP1 enhancement followed by late-phase SPP1 ...

Skeptic

# Critical Evaluation of SPP1 Therapeutic Hypotheses ## Overall Methodological Concerns Before evaluating individual hypotheses, several cross-cutting issues merit attention: **Fundamental Evidence...

Domain Expert

# Feasibility Assessment: SPP1 Therapeutic Hypotheses ## Scope and Framework Seven hypotheses survived initial scrutiny at varying credibility levels. Two hypotheses (H1, H6) present fatal or near-f...

Synthesizer

{"ranked_hypotheses":[{"title":"TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from Destructive to Restorative","description":"TREM2 haploinsufficiency shifts SPP1-mediated ...

Differential Complement Regulator Expression on Sy

4 rounds · quality: 0.75

Theorist

# Therapeutic Hypotheses: Selectivity of Complement-Mediated Synaptic Elimination During Prolonged Anesthesia --- ## Hypothesis 1: Activity-Dependent Synaptic Tagging via CREB-BDNF TrkB Signaling *...

Skeptic

# Critical Evaluation of Hypotheses for Complement-Mediated Synaptic Selectivity ## Overview These hypotheses address a legitimate gap in understanding how C1q distinguishes between synapses for eli...

Domain Expert

# Feasibility Assessment: Selectivity Mechanisms in Anesthesia-Induced Synaptic Elimination ## Executive Summary The central question—whether specific synapses become targets for complement-mediated...

Synthesizer

{ "ranked_hypotheses": [ { "title": "Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)", "description": "Excitatory synapses on specific neuronal compart...